A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

NCT07024602 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: ASC50 tablets or matching placebo

Sponsor

Ascletis Pharma (China) Co., Limited